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Emerging data suggest that the gut microbiome is related to the pathophysiology of obesity. This study is aimed at characterizing
the gut microbiota composition between obese and normal-weight Korean children aged 5-13. We collected fecal samples from 22
obese and 24 normal-weight children and performed 16S rRNA gene sequencing using the Illumina MiSeq platform. The relative
abundance of the phylum Bacteroidetes was lower in the obese group than in the normal-weight group and showed a significant
negative correlation with BMI z-score. Linear discriminative analysis (LDA) coupled with effect size measurement (LEfSe)
analysis also revealed that the Bacteroidetes population drove the divergence between the groups. There was no difference in
alpha diversity, but beta diversity was significantly different between the normal-weight and obese groups. The gut microbial
community was linked to BMI z-score; blood biomarkers associated with inflammation and metabolic syndrome; and dietary
intakes of niacin, sodium, vitamin B6, and fat. The gut microbiota of the obese group showed more clustering of genera than
that of the normal-weight group. Phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt)
analysis revealed that the functions related to carbohydrate and lipid metabolism in the microbiota were more enriched in the
normal-weight group than in the obese group. Our data may contribute to the understanding of the gut microbial structure of
young Korean children in relation to obesity. These findings suggest that Bacteroidetes may be a potential therapeutic target in
pediatric obesity.
1. Introduction
Childhood obesity is a major public health concern world-
wide [1]. Obese children have a high risk of developing adult
obesity and obesity-related comorbidities, including type 2
diabetes mellitus, cardiovascular disease, and psychological
problems [2, 3]. Recently, accumulating evidence suggests
that the human gut microbiota is associated with many
chronic diseases, including obesity. Previous studies in adults
have demonstrated that obese individuals have different
microbial compositions than lean individuals [4, 5]. The
gut microbiota is closely related to energy harvest and metab-
olism in humans [6, 7]. Therefore, microbiota-targeted strat-
egies have attracted much attention in the context of obesity
treatment [8, 9].
Studies on the obesity-related microbiota in children are
still scarce. Gut microbial composition is known to vary with
age, ethnicity, and diet [6, 10]. Although previous studies
have suggested that the gut microbiota of infants is converted
into adult-like composition in the first 1-3 years [11], some
evidence indicates that the microbiota continues to change
until adolescence [12]. Therefore, valuable information on
the obesity-related microbiota could be obtained from differ-
ent ethnic and age groups.
The objective of this study was to characterize the com-
position of the gut microbiota among obese and normal-
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weight Korean children. Amplicons of the 16S rRNA gene
were sequenced using Illumina MiSeq to analyze the compo-
sition of the gut microbiota. The dietary and lifestyle patterns
of the participants and the levels of blood biochemical
markers related to inflammation and metabolic disease were
measured and examined in relation to the gut microbiota
composition. The correlation structure of the microbiota
was shown using network analysis, and predictive functional
differences between groups were identified by phylogenetic
investigation of communities by reconstruction of unob-
served states (PICRUSt) analysis.
2. Materials and Methods
2.1. Subjects, Questionnaire, and Anthropometric
Measurements. Forty-six children who were 5-13 years of
age were enrolled in the study at Hallym University Kang-
nam Sacred Heart Hospital from December 2017 to March
2018 (NCT03388411). This study protocol was approved by
the Institutional Review Board of the Hallym University
Kangnam Sacred Heart Hospital (2017-09-015). Written
informed consent was obtained from all subjects of the study
and their parents, in accordance with the Declaration of Hel-
sinki. Based on the 2017 Korean growth chart [13], subjects
with a bodymass index ðBMIÞ ≥ 95th percentile were classi-
fied as the obese group, and subjects with 5th percentile <
BMI < 85th percentile were classified as the normal-weight
group. For a month prior to the stool sampling, none of the
subjects had taken antibiotics/probiotics/steroids or had
diarrhea. None of the subjects had acute infections or chronic
disease. Subjects completed questionnaires on lifestyle, bowel
habits, and dietary intake and submitted them at the hospital
visit. Anthropometric measurements, including height,
weight, waist circumference, midarm circumference, hip cir-
cumference, thigh circumference, and blood pressure, were
performed by professionally trained personnel [14, 15]. Body
composition analysis including skeletal muscle mass and
total body fat content was measured using the inBody 770
analyzer (Biospace Co. Ltd., Seoul, Korea).
2.2. Dietary Assessments. The children and their parents
received specific training from a dietitian to describe in a
proper way all the foods and the quantities consumed,
including the name/brand of the consumed food, recipes of
dishes, method of preparation or cooking, and portion sizes.
After training with the dietitian, the participants filled out
everything the subjects ate and drank for 3 days: 2 weekdays
and 1 weekend day. Using data from the dietary records,
nutrient intakes were calculated by a dietitian using the
Computer-Aided Analysis Program 4.0 for professionals
(CAN-pro 4.0, Korean Nutrition Society, Seoul, Korea).
2.3. Blood Sampling and Biochemical Analysis. After a 12-
hour overnight fast, blood samples were taken from the sub-
jects. The levels of glucose, aspartate aminotransferase (AST),
alanine aminotransferase (ALT), insulin, total cholesterol,
triglycerides, high-density lipoprotein- (HDL-) cholesterol,
low-density lipoprotein- (LDL-) cholesterol, high-sensitivity
C-reactive protein (hs-CRP), uric acid, iron, and unsaturated
iron binding capacity (UIBC) were measured using a Hitachi
7600 autoanalyzer (Hitachi, Tokyo, Japan). Total iron bind-
ing capacity (TIBC) was calculated as the sum of the serum
iron and UIBC levels. Transferrin saturation (Tf%) was cal-
culated as ðserum iron/ðserum iron + UIBCÞÞ × 100. Concen-
trations of ferritin, insulin, and 25-OH vitamin D were
determined using an ADVIA Centaur XP (Siemens Health-
care Diagnostics, Deerfield, IL, USA). The complete blood
count was analyzed by an ADVIA 2120i (Siemens Healthcare
Diagnostics, Tarrytown, NY, USA). The neutrophil-to-
lymphocyte ratio (NLR) was calculated as the ratio of the
neutrophil count to the lymphocyte count. The hemoglobin
A1c (HbA1c) level was determined using a D-100 system
(Bio-Rad Laboratories, Hercules, CA, USA). Insulin resis-
tance and beta-cell function were evaluated by the homeosta-
sis model assessment methods (HOMA-IR and HOMA-%B,
respectively). HOMA-IR was calculated as ðinsulin ðμIU/
mLÞ × glucose ðmg/dLÞÞ/405, and HOMA-%Bwas calculated
as ð20 × insulin ðμIU/mLÞÞ/ðglucose ðmg/dLÞ/18‐3:5Þ.
2.4. Stool Sampling, Bacterial DNA Extraction, Illumina
MiSeq Sequencing, and Bioinformatics. The stool samples
were collected in sterile containers and immediately frozen
at -80°C until DNA extraction. DNA was extracted using a
QIAamp DNA Stool Mini Kit (Qiagen, Valencia, CA, USA)
according to the manufacturer’s instructions. Using 2μL of
the extracted DNA, polymerase chain reaction (PCR) ampli-
fications were performed with the primers targeting the V3 to
V4 regions of the 16S rRNA gene [16]. The products were
then amplified by the second PCR with index primers. Equal
concentrations of amplicons were pooled together and puri-
fied using an AMPure bead kit (Agencourt Bioscience, Bev-
erly, MA, USA). The product size and quality were assessed
on an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo
Alto, CA, USA). Sequencing was carried out at ChunLab,
Inc. (Seoul, Korea) using the Illumina MiSeq platform (Illu-
mina, San Diego, CA, USA). The raw reads were checked
for quality, and low-quality reads (average score < 25) were
filtered by a Trimmomatic tool (version 0.32). Then, the
paired-end sequences were merged using a PANDASeq
Paired-end Assembler [17]. Chimeric sequences were
removed using the UCHIME algorithm [18]. The taxonomic
classification of each read was performed based on the
EzBioCloud database (http://eztaxon-e.ezbiocloud.net) [19].
Sequences that corresponded to the reference sequence with
greater than 97% similarity in EzBioCloud were considered
to be identified at the species level. To compare the opera-
tional taxonomic units (OTUs) between samples, we deter-
mined shared OTUs through the EzBioCloud program
(Chunlab Inc.). The functional potential of the microbiota
was inferred using PICRUSt metagenomics prediction [20]
and was categorized into levels 1-3 based on Kyoto Encyclo-
pedia of Genes and Genomes (KEGG) pathways [21].
2.5. Statistical Analysis. All statistical analyses were carried
out using R software (version 3.5.2, http://www.r-project
.org/). Based on the Shapiro-Wilk normality test, data are
presented as the means and standard deviations (for contin-
uous variables with normal distribution) or medians and
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interquartile ranges (for continuous variables with skewed
distribution). Categorical variables are expressed as frequen-
cies and percentages. In analyzing the characteristics, nutri-
ent intake, and blood biochemical profiles of the
participants, the t-test or the Kruskal-Wallis Rank Sum test
was used according to the results of the normality test. For
comparison of the gut microbiota between groups, the
Mann-Whitney U test was used for continuous variables,
and chi-square was used for categorical variables. Correla-
tions between continuous variables were calculated using
the Pearson correlation test. All analyses were performed
after normalizing for the copy number of the bacterial 16S
rRNA gene. The ACE index, the number of observed OTUs,
the Chao1 richness estimate, and the Jackknife estimate were
used to compare gut microbiota richness between samples.
The within sample (alpha) diversity was compared using
the Simpson diversity index, the Shannon index, and phylo-
genetic diversity. Cluster analysis was performed with non-
metric multidimensional scaling (NMDS), after computing
the Bray-Curtis dissimilarity between each pair of individ-
uals. The Fast UniFrac analysis was used to calculate the
(beta) diversity between groups and was visualized with a
principal coordinate analysis (PCoA). Differences in beta
diversity between the normal-weight and obese groups were
tested with nonparametric analysis of variance based on
999 permutations (permutational multivariate analysis of
variance (PERMANOVA)). The differently abundant bacte-
rial taxa between the normal-weight and obese groups were
identified using the linear discriminant analysis (LDA)
coupled with effect size measurement (LEfSe) method [22].
To analyze the ability of specific taxa to predict obesity, we
calculated the area under the receiver operating characteristic
curve (AUC of ROC). Multivariate analysis for relationships
between gut microbial community composition, BMI z
-score, and blood biochemical markers was performed using
canonical correspondence analysis (CCA). Using the R pack-
age qgraph [23], we performed a network analysis to identify
the difference in the correlation network of the gut microbi-
ota between the normal-weight and obese groups. To obtain
the relative robustness, the sample coverage threshold for the
identified genera was set at ≥0.5. The resulting p values were
adjusted for multiple testing with the false discovery rate
(FDR) method [24]. p values ≤ 0.05 were considered statisti-
cally significant.
3. Results
3.1. Participant Characteristics, Lifestyle Questionnaire, and
Blood Biochemical Marker. A total of forty-six children were
enrolled in this study (obese group: n = 22; normal-weight
group: n = 24). The characteristics of the participants are
summarized in Table 1. The sex distribution showed no dif-
ference between the normal-weight and obese groups
(p = 0:853; Table 1). The individuals in the normal-weight
group were slightly younger than those in the obese group
(p = 0:048; Table 1). All anthropometric measurements,
including height (p = 0:002), weight (p < 0:001), BMI
(p < 0:001), BMI z-score (p < 0:001), waist circumference
(p < 0:001), midarm circumference (p < 0:001), hip circum-
ference (p < 0:001), and thigh circumference (p < 0:001),
showed significantly higher values in the obese group than
in the normal-weight group (Table 1). Systolic/diastolic
blood pressure (p = 0:002/p < 0:001), skeletal muscle mass
(p < 0:001), and total body fat content (p < 0:001) also
showed significantly higher values in the obese group than
in the normal-weight group (Table 1). The percentage of
children born by cesarean section was significantly higher
in the obese group (p = 0:012; Table 1). Questionnaires on
lifestyle patterns differed between the normal-weight and
obese groups. The percentage of children who did not exer-
cise at all was 36.4% in the obese group and 0% in the
normal-weight group (p = 0:004; Table 1). The percentage
of children who exercised for 30 minutes or more per day
was significantly higher in the normal-weight group than in
the obese group (p = 0:025; Table 1). The percentage of chil-
dren who watched television or used electronic devices (video
games, smart phones, or computers) more than two hours a
day was significantly higher in the obese group than in the
normal-weight group (p = 0:017; Table 1). The percentage
of children who used electronic devices near bedtime tended
to be higher in the obese group than in the normal-weight
group (p = 0:072; Table 1).
Analysis of energy and nutrient intakes from three-day
dietary records showed significant differences in total
energy (p < 0:001), protein (p < 0:001), fat (p = 0:001), car-
bohydrate (p = 0:028), cholesterol (p = 0:002), total fatty acid
(p = 0:010), polyunsaturated fatty acid (p = 0:001), trace
mineral (phosphorus, iron, sodium, potassium, and zinc
(p < 0:05)), and vitamin (thiamine, niacin, vitamin B6, and
vitamin E (p = 0:004)) intakes between the normal-weight
and obese groups (Table 2).
Among the measured blood biochemical markers, glu-
cose (p = 0:027), ALT (p = 0:018), triglycerides (p = 0:003),
LDL-cholesterol (p = 0:021), hs-CRP (p < 0:001), uric acid
(p = 0:032), ferritin (p < 0:001), insulin (p < 0:001), HOMA-
IR (p < 0:001), HOMA-%B (p < 0:001), mean platelet volume
(MPV) (p = 0:017), white blood cell (WBC) count (p = 0:039),
neutrophil percentage (p = 0:003), and NLR (p = 0:024)
were significantly higher in the obese group than in the
normal-weight group (Table 3). On the other hand, HDL-
cholesterol (p = 0:025), 25-OH vitamin D (p = 0:002), and
lymphocyte percentage (p = 0:047) were significantly lower
in the obese group than in the normal-weight group
(Table 3).
3.2. Gut Microbial Composition and Diversity. After filtering
low-quality, nontarget, and chimeric amplicons, 16S rRNA
gene sequencing resulted in a total of 3.9 million high-
quality reads from 46 fecal samples. The median sequencing
read was 78,155 (quartiles: 69,929; 85,731). We obtained a
median value of 412.5 OTUs per sample (316; 529.3) after
excluding low-abundance OTUs (<1% of total).
At the phylum level, the predominant bacterial taxa were
Firmicutes and Bacteroidetes, followed by Actinobacteria and
Proteobacteria in both groups (Figures 1(a) and 1(b)). The
relative abundance of the phylum Bacteroidetes was signifi-
cantly decreased in obese children (obese group: median
36.6 (0.3; 52.9); normal-weight group: 45.2 (10.5; 69.1))
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(p = 0:007; Figure 1(c)). The relative abundance of Bacteroi-
detes was significantly negatively correlated with BMIz
-score (Figure 1(d)). The ROC analysis of Bacteroidetes for
predicting obesity showed good performance (AUC: 0.7443;
95% confidence interval (CI): 0.603-0.8856), unlike the anal-
ysis of Firmicutes (AUC: 0.5606; 95% CI: 0.3839-0.7373)
(Figure 1(e)). Multivariate regression analysis showed that
the log-transformed BMI z-score and the log-transformed
relative abundance of major taxa belonging to the phylum
Bacteroidetes were negatively associated after adjusting for
age, sex, and delivery type (beta = −3:12, standard estimates
= 11:06; Figure 1(f)). In the stepwise logistic regression
model, the odds ratio for risk of obesity associated with Bac-
teroidetes at the phylum level was 0.87 after adjusting for age,
Table 1: Characteristics of the study participants.∗.
Normal-weight (n = 24) Obese (n = 22) p†
Sex (male, n %) 18 (75.0%) 15 (68.2%) 0.853
Age (years) 8:1 ± 1:5 9 ± 1:5 0.048
Anthropometric measurements
Weight (kg) 27.3 (24.9; 30.1) 46.4 (42.0; 52.9) <0.001
Weight (z-score) 0:7 ± 0:5 2:2 ± 0:5 <0.001
Height (cm) 129:5 ± 9:4 139:1 ± 10:8 0.002
Height (z-score) 0:6 ± 0:5 1 ± 0:7 0.035
BMI† (kg/m2) 16.6 (15.5; 17.6) 24.4 (22.9; 25.7) <0.001
BMI (z-score) 0.6 (0.4; 0.9) 2.5 (2.1; 2.8) <0.001
Systolic blood pressure 98.5 (90.0; 111.5) 110.0 (100.0; 120.0) 0.002
Diastolic blood pressure 60.0 (60.0; 63.5) 70.0 (60.0; 70.0) <0.001
Waist circumference (cm) 58.5 (55.5; 61.8) 77.8 (74.0; 81.5) <0.001
Waist-to-height ratio 0:5 ± 0 0:6 ± 0 <0.001
Midarm circumference (cm) 20:3 ± 2:7 26:7 ± 2:8 <0.001
Hip circumference (cm) 69:9 ± 6:7 86:3 ± 8:0 <0.001
Thigh circumference (cm) 39.0 (35.6; 41.1) 46.0 (44.5; 51.5) <0.001
Total body fat content (%) 22.1 (19.6; 26.4) 39.2 (33.8; 40.2) <0.001
Skeletal muscle mass (kg) 10.2 (9.3; 11.3) 16.4 (13.9; 19.1) <0.001
Delivery type 0.012
Vaginal : cesarean 18 (75.0%) : 6 (25.0%) 7 (33.3%) : 14 (66.7%)
Lifestyle pattern
Study time after school 0.094
≤1 hour 7 (29.2%) 1 (5.0%)
>1 hour 17 (70.8%) 19 (95.0%)
Exercise during the day 0.004
Yes 24 (100.0%) 14 (63.6%)
No 0 (0.0%) 8 (36.4%)
Exercise time during the day 0.025
≤30min 2 (8.3%) 9 (40.9%)
>30min 22 (91.7%) 13 (59.1%)
Exercise time during the day 0.219
≤1 hour 11 (45.8%) 15 (68.2%)
>1 hour 13 (54.2%) 7 (31.8%)
Time spent watching TV or using electronic devices 0.017
≤2 hours 20 (83.3%) 10 (45.5%)
>2 hours 4 (16.7%) 12 (54.5%)
Use electronic device for more than an hour before sleeping 0.072
Yes 4 (16.7%) 10 (45.5%)
No 20 (83.3%) 12 (54.5%)
∗Data are expressed as the mean ± standard deviation, median (interquartile range), or a number (%). †Significant p values are shown in bold. Abbreviations:
AST—aspartate aminotransferase.
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sex, and delivery type (95% CI: 0.80-0.95; p = 0:003)
(Table 4).
There was no significant difference in the relative abun-
dance of Firmicutes (obese: 53.1 (45.1; 73.3); normal-weight:
45.7 (24.7; 76.6)), Actinobacteria (obese: 1.28 (0.56; 10.55);
normal-weight: 0.89 (0.31; 2.99)), or Proteobacteria (obese:
8.5 (1.41; 15.0); normal-weight: 5.34 (1.72; 11.12))
(p = 0:053, p = 0:235, and p = 0:416, respectively; Supple-
mentary Figures S1A, S1B, and S1C). The Firmicutes-to-
Bacteroidetes (F : B) ratio was significantly elevated in obese
children (obese: 1.5 (0.9; 18.4); normal-weight: 1.1 (0.4;
2.9)) (p = 0:012; Supplementary Figure S1D). Among
family-level taxa, the relative abundance of Lachnospiraceae
was significantly higher in the obese group than in the
normal-weight group (obese: 13.49 (10.97; 18.24); normal-
weight: 9.9 (7.52; 12.94)) (p = 0:022; Supplementary Figure
S2A). Among taxa at the species level, the abundance of
Bacteroides ovatus was significantly lower in the obese
group than in the normal-weight group (obese: 0.07 (0.02;
1.04); normal-weight: 1.04 (0.67; 2.8)) (p = 0:022;
Figure S2B). There was no difference in the abundance of
the genus Akkermansia between the groups (obese: 0.01 (0;
0.05); normal-weight: 0.14 (0; 1.27)) (p = 0:356;
Supplementary Figure S2C).
We analyzed the correlation between BMI z-score and
the relative abundance of bacterial taxa (Table 5). The rela-
tive abundance of the phylum Bacteroidetes was negatively
correlated with BMI z-score (Pearson’s correlation coeffi-
cient r = −0:329, p = 0:026; Figure 1(d)). Furthermore, BMI
z-score was negatively correlated with the abundance of Bac-
teroidia at the class level; Bacteroidales at the order level; and
Bacteroidaceae, Devosia_f, Leptotrichiaceae, Odoribactera-
ceae, Porphyromonadaceae, Rikenellaceae, and Staphylococ-
caceae at the family level (Table 5). The relative abundance
of the family Lachnospiraceae was positively correlated with
BMI z-score (p = 0:05; Table 5). The relative abundance of
the phylum Firmicutes was not significantly correlated with
BMI z-score (r = 0:24, p = 0:1).
Gut microbiota richness measures showed no obvious
difference between samples from normal-weight and obese
children (ACE, p = 0:725; the number of observed OTUs, p
= 0:692; the Chao1 richness estimate, p = 0:676; and the
Jackknife estimate, p = 0:775). In addition, several alpha
diversity estimates, including the Simpson diversity index
Table 2: Energy and nutrient intake of the participants.∗.
Normal-weight (n = 24) Obese (n = 22) p†
Energy (kCal) 1543:4 ± 375:9 2027:9 ± 405:5 <0.001
Protein (g) 56:3 ± 18:4 82:0 ± 23:2 <0.001
Fat (g) 40:9 ± 14:0 62:8 ± 25:1 0.001
Carbohydrates (g) 240:6 ± 62:4 284:9 ± 68:4 0.028
Ca (mg) 486:5 ± 229:6 505:7 ± 277:9 0.801
P (mg) 889:3 ± 316:5 1173:7 ± 405:0 0.011
Iron (mg) 10:2 ± 4:4 15:0 ± 5:0 0.002
Na (mg) 2726:6 ± 1099:2 4105:3 ± 1073:9 <0.001
K (mg) 2076:5 ± 757:0 2566:7 ± 781:4 0.039
Zinc (mg) 8:1 ± 2:5 11:0 ± 2:8 0.001
Folic acid (μg) 430:1 ± 229:6 448:9 ± 186:6 0.767
β-Carotene (μg) 2430.8 (1691.5; 3646.6) 3350.5 (1979.1; 5071.1) 0.260
Retinol (μg) 100.1 (69.1; 199.6) 157.5 (97.3; 305.2) 0.104
Thiamine (mg) 1:0 ± 0:3 1:4 ± 0:5 0.002
Riboflavin (mg) 1:2 ± 0:5 1:4 ± 0:6 0.296
Niacin (mg) 11:3 ± 5:0 18:2 ± 6:7 <0.001
Vitamin B6 (mg) 1.0 (0.9; 1.4) 1.6 (1.3; 2.0) 0.001
Vitamin C (mg) 95.4 (40.3; 226.9) 87.6 (52.2; 123.5) 0.532
Vitamin D (μg) 2.6 (1.5; 6.0) 3.1 (2.0; 4.9) 0.891
Vitamin E (mg) 11:8 ± 5:0 18:1 ± 8:0 0.004
Fiber (g) 15.7 (11.8; 19.2) 16.9 (16.0; 18.8) 0.191
Cholesterol (mg) 250:1 ± 149:3 431:3 ± 224:9 0.002
Total fatty acid (mg) 23:8 ± 8:4 37:4 ± 21:0 0.010
Saturated fatty acid (mg) 9.7 (6.6; 12.1) 12.1 (6.0; 19.9) 0.094
Polyunsaturated fatty acid (mg) 6:0 ± 2:9 11:1 ± 5:5 0.001
∗Data are expressed as the mean ± standard deviation, median (interquartile range), or a number (%). †Significant p values are shown in bold.
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(p = 0:262), the Shannon index (p = 0:272), and phylogenetic
diversity (p = 0:982), were not significantly different between
normal-weight and obese children. NMDS analysis revealed
separation and clustering of the obese group from the
normal-weight group along the NMDS1 axis, while naïve
tended to cluster along NMDS2 (Figure 1(g)). We used the
Fast UniFrac analysis to measure beta diversity. The PCoA
plot of the microbiota from all individuals in the normal-
weight and obese groups is shown in Figure 1(h). The beta
diversity showed a statistically significant difference between
normal-weight and obese children at the genus level
(p = 0:009, PERMANOVA on Fast UniFrac distances;
Figure 1(h)).
3.3. Taxonomic Differences in the Microbiota between Obese
and Normal-Weight Children. To identify the specific micro-
bial profile distinguishing obese and normal-weight children,
a metagenomics biomarker discovery approach using the
LEfSe method was applied to assess the effect size of each dif-
ferently abundant taxon (Figure 2). The LDA effect size
values are shown in Figure 2(f). Using the LEfSe method,
we found that Bacteroidetes at the phylum level; Bacteroidia
at the class level; Bacteroidales at the order level; Bacteroida-
ceae, Porphyromonadaceae, and Rikenellaceae at the family
level; and Bacteroides, EF404788_g, Desulfovibrio_g3, Anae-
rofilum, Alistipes, Bacteroidaceae_uc, Hydrogenoanaerobac-
terium, EF402988_g, Oscillibacter, and Citrobacter at the
Table 3: Blood biochemical profiles of the participants.∗.
Normal weight (n = 24) Obese (n = 22) p†
Glucose (mg/dL) 97:2 ± 4:8 102 ± 6:7 0.027
AST (IU/L) 29.0 (25.0; 33.0) 25.0 (22.0; 26.0) 0.027
ALT (IU/L) 13.5 (13.0; 19.0) 19.5 (16.0; 29.0) 0.018
Total cholesterol (mg/dL) 168 ± 24:1 180 ± 25:1 0.165
Triglycerides (mg/dL) 47.5 (43.0; 67.0) 81.0 (61.0; 132.0) 0.003
HDL-cholesterol (mg/dL) 63:5 ± 11:3 54 ± 12:1 0.025
LDL-cholesterol (mg/dL) 94 ± 19:4 111:9 ± 22:9 0.021
hs-CRP (mg/L) 0.3 (0.2; 0.4) 2.1 (0.7; 3.1) <0.001
Uric acid (mg/L) 4:2 ± 0:8 5 ± 1:3 0.032
Iron (μg/dL) 104:4 ± 45:3 92 ± 33:7 0.353
TIBC (μg/dL) 330:4 ± 27:3 347:2 ± 32:2 0.115
Transferrin saturation (%) 31:4 ± 12:5 26:6 ± 9:9 0.212
25-OH vitamin D (ng/mL) 15 ± 4:5 10:8 ± 3:2 0.002
Ferritin (ng/mL) 33:6 ± 14:3 62:8 ± 26:8 <0.001
Insulin (μU/mL) 4.9 (3.8; 6.8) 13.8 (9.6; 18.6) <0.001
HOMA-IR 1.2 (0.9; 1.8) 3.5 (2.4; 4.4) <0.001
HOMA-%B 51.5 (43.0; 66.4) 122.4 (98.8; 172.9) <0.001
Hemoglobin (g/dL) 13:4 ± 0:9 13:3 ± 0:8 0.955
HbA1c (%) 5.2 (5.1; 5.5) 5.3 (5.2; 5.5) 0.188
Platelet count (×103/μL) 312:8 ± 53 325:1 ± 67:7 0.567
MPV (fL) 7.2 (6.7; 7.3) 7.4 (7.1; 8.0) 0.017
PDW (%) 43.0 (41.2; 51.2) 48.0 (44.2; 50.4) 0.115
WBC count (×103/μL) 6 ± 1:1 7 ± 1:5 0.039
Neutrophil count 2:6 ± 0:7 3:6 ± 1:0 0.003
Neutrophil (%) 43:1 ± 9:2 50:6 ± 8:1 0.015
Lymphocyte count (×103/μL) 2:7 ± 0:7 2:8 ± 0:9 0.911
Lymphocyte (%) 45:2 ± 8:6 39:2 ± 8:6 0.047
Monocyte count (×103/μL) 0:3 ± 0:1 0:3 ± 0:1 0.519
Eosinophil count (×103/μL) 0:2 ± 0:1 0:2 ± 0:1 0.853
Basophil count (×103/μL) 0.0 (0.0; 0.0) 0.0 (0.0; 0.0) 0.474
Neutrophil-to-lymphocyte ratio 0.8 (0.7; 1.2) 1.2 (1.0; 1.7) 0.024
∗Data are expressed as the mean ± standard deviation, median (interquartile range), or a number (%). †Significant p values are shown in bold. Abbreviations:
AST—aspartate aminotransferase; ALT—alanine aminotransferase; HDL—high-density lipoprotein; LDL—low-density lipoprotein; hs-CRP—high-sensitivity
C-reactive protein; TIBC—total iron binding capacity; MPV—mean platelet volume; PDW—platelet distribution width; WBC—white blood cell.
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Figure 1: Gut microbiota composition in the normal-weight (a) and obese (b) groups. The inner circle shows the composition at the phylum
level, and the outer circle shows the composition at the family level. Violin plot showing the median, spread, and distribution pattern of the
relative abundance of Bacteroidetes between the obese group and the normal-weight group (c). Correlation scatter plot of the relative
abundance (%) of Bacteroidetes and BMI z-scores of participants (d). Receiver operator characteristic (ROC) curve of the relative
abundance of Bacteroidetes to predict obesity (e). The area under the curve (AUC) was 0.74 (95% CI: 0.60-0.89). Interaction between
Bacteroidetes and BMI z-score (F). Cluster analysis was performed with NMDS analysis using Bray-Curtis distance (g). Principal
coordinate analysis of the gut microbiota at the genus level according to the normal-weight (red) and obese (blue) groups (h). Principal
components (PCs) 1, 2, and 3 explained 36.379%, 10.656%, and 9.43% of the variance, respectively (h). This result suggests that the gut
microbial composition observed in the obese group was significantly different from that of the normal-weight group (p = 0:009,
PERMANOVA on Fast UniFrac distances).
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genus level were significantly enriched in the normal-weight
group (p < 0:05; Figure 2). This population is dominated by
bacteria belonging to the Bacteroidetes phyla in the normal-
weight group. In addition, Actinomyces, Romboutsia, Weis-
sella, and GL872355_g at the genus level were significantly
enriched in the obese group (p < 0:05; Figure 2).
3.4. Relationship between Gut Microbial Community
Composition, BMI z-Score, Blood Biochemical Markers, and
Dietary Intake. We generated a correlogram to visualize the
degree of association between BMI z-score, major phyla,
blood biochemical markers, and dietary intake of energy
and nutrients (Figure 3(a)). Variables with highly significant
differences between the two groups (p value ≤ 0.1) were
selected from the univariate analysis. Variables with a corre-
lation coefficient (r) of 0.8 or greater were regarded as the
same variables, and then one representative variable was
selected from the same variables. The BMI z-score showed
a significant positive correlation with inflammatory markers,
including HOMA-IR; neutrophil count; and serum levels of
triglycerides, hs-CRP, and ferritin, and with increased dietary
intake of calories, fat, niacin, vitamin B6, P, Na, and zinc
(Figure 3(a)). On the other hand, serum vitamin D levels
and the proportion of Bacteroidetes were negatively corre-
lated with BMI z-score (Figure 3(a)). The Actinobacteria
population showed negative correlations with the Bacteroi-
detes and Proteobacteria populations and positive correla-
tions with blood markers including hs-CRP and neutrophil
count and with dietary intake of calories and fat
(Figure 3(a)). The correlogram showed that Bacteroidetes
and Firmicutes exhibited different orientations in regard to
correlation with most of the variables, including blood bio-
markers and dietary intakes (Figure 3(a)). The Bacteroidetes
population showed a negative correlation with the Firmicutes
population and a positive correlation with the Proteobacteria
population (Figure 3(a)). Moreover, the proportion of Bac-
teroidetes was negatively correlated with inflammatory
markers, including hs-CRP, ferritin, HOMA-IR, and neutro-
phil count, and with dietary intake of calories, fat, niacin,
vitamin B6, P, Na, and zinc (Figure 3(a)). On the other hand,
the Firmicutes population showed a negative correlation with
the proportion of Proteobacteria and positive correlations
with the inflammatory markers hs-CRP and neutrophil
count and with dietary intake of calories, fat, niacin, vitamin
B6, and Na (Figure 3(a)).
We performed CCA to visualize the relationship between
gut microbial community composition, BMI z-scores, and
blood biochemical markers (Figure 3(b)) or dietary intake
(Figure 3(c)). Variables were selected from the same stan-
dards with the correlogram. The distance between two points
shows the significance of the correlation. The distance
between Bacteroidetes and the microbial community in the
normal-weight group is shorter than that between Firmicutes
and the microbial community in the normal-weight group,
suggesting that Bacteroidetes has a strong correlation with
the normal-weight group (Figures 3(b) and 3(c)). The length
of the blue line is proportional to the degree of importance.
As shown in Figure 3(b), BMI z-score, HOMA-IR, hs-CRP,
ferritin, and neutrophil count are more important in the
microbial community of the obese group, whereas vitamin
D is an important factor in the microbial community of the
normal-weight group. Figure 3(c) shows that fat, Na, and nia-
cin among dietary components, in addition to BMI z-score,
are more important in the microbial community of the obese
group, whereas vitamin B6 intake is an important factor in
the microbial community of the normal-weight group. Fir-
micutes was negatively correlated with serum vitamin D
levels and dietary intake of vitamin B6 (Figures 3(b) and
3(c)). Bacteroidetes was negatively correlated with BMI z
-score, serum ferritin level, and fat intake (Figures 3(b) and
3(c)). Actinobacteria showed a negative correlation with
HOMA-IR and dietary intake of Zn, P, niacin, and Na
(Figures 3(b) and 3(c)). Proteobacteria was negatively corre-
lated with neutrophil count and hs-CRP (Figures 3(b) and
3(c)).
3.5. Correlation Network. We performed a correlation net-
work analysis to investigate whether obesity was associated
with alterations in the overall correlation structure of the
gut microbiota (Figure 4 and Supplementary Table S1).
Constructed networks revealed that samples from the
normal-weight group had fewer edges, a lower mean
degree, and a longer mean distance than those from the
obese group, which indicates that there were fewer
significant correlations and less clustering of genera
(Supplementary Table S2). The betweenness centrality was
higher in the obese group, which indicates that only a few
genes were highly correlated in a network (Supplementary
Table S2). Bacteroidetes showed higher positive
intraphylum correlations in the normal-weight group, and
Firmicutes showed higher positive intraphylum correlations
in the obese group (Supplementary Table S2).
3.6. PICRUSt. To investigate the differences in microbial
functions between the normal-weight and obese groups, we
assessed the microbial community functional potential using
PICRUSt analysis. The distribution of tier 1 KEGG func-
tional categories was similar between the normal-weight
and obese groups (Figure 5(a)). The largest number of genes
(approximately 48%) corresponded to a function that
encoded proteins involved in “metabolism” among tier 1
KEGG categories. Then, we examined which metabolic path-
ways in the tier 2 and tier 3 KEGG categories showed statis-
tically significant differences between the normal-weight and
Table 4: Association between taxa and risk of obesity analyzed by
logistic regression.
Level Taxa Adjusted odds ratio∗ 95% CI p
Phylum Bacteroidetes 0.87 0.80-0.95 0.003
Class Bacteroidia 0.87 0.80-0.95 0.003
Order Bacteroidales 0.87 0.80-0.95 0.003
Family Bacteroidaceae 0.90 0.84-0.97 0.004
Genus Bacteroides 0.90 0.84-0.97 0.004
∗Adjusted for age, sex, and delivery type. Abbreviation: CI—confidence
interval.
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Table 5: Bacterial taxa correlated with BMI z-score.
Level Taxa r∗ p∗∗
Phylum Bacteroidetes -0.329 0.026
Class Bacteroidia -0.329 0.026













































Allisonella histaminiformans 0.314 0.034
Anaerobium_uc 0.389 0.008
Anaerotruncus colihominis -0.372 0.011
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Table 5: Continued.
Level Taxa r∗ p∗∗
Atopostipes suicloacalis -0.33 0.025BCAB_s -0.304 0.04
Bacteroides finegoldii -0.377 0.01
Bacteroides oleiciplenus -0.322 0.029
Bacteroides ovatus -0.322 0.029
Bacteroides uniformis -0.345 0.019
Butyricicoccus_uc 0.323 0.029
Caproiciproducens_uc -0.34 0.021
Catenibacterium mitsuokai 0.315 0.033
Clostridium_g12_uc 0.348 0.018
Clostridium_g6_uc 0.317 0.032




Desulfovibrio acrylicus group -0.395 0.007

















Fusobacterium hwasookii 0.304 0.04
Fusobacterium nucleatum group 0.305 0.039









Klebsiella oxytoca group 0.353 0.016
LARM_s -0.303 0.041
Lachnoanaerobaculum orale group -0.355 0.015
Megasphaera_uc 0.337 0.022
PAC000196_s -0.389 0.008
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obese groups (Supplementary Table S3). In the tier 2 KEGG
categories, the microbiota of the normal-weight group was
enriched in the functional abundance of “metabolism of
terpenoids and polyketides” (p = 0:032), “lipid metabolism”
(p = 0:032), “carbohydrate metabolism” (p = 0:028), and
“biosynthesis of other secondary metabolites” (p = 0:032)
(Figure 5(b)). In the tier 3 KEGG categories, several
pathways were enriched in the gut microbiota of the
normal-weight group: “biotin metabolism” (p = 0:011),
“glycosaminoglycan degradation” (p = 0:009),
“glycosphingolipid biosynthesis-ganglio series” (p = 0:007),
“glycosphingolipid biosynthesis-globo and isoglobo series”
(p = 0:009), “inositol phosphate metabolism” (p = 0:004),
“other glycan degradation” (p = 0:013), “phenylpropanoid
biosynthesis” (p = 0:032), “phosphonate and phosphinate
metabolism” (p = 0:001), “sphingolipid metabolism”
(p = 0:015), “steroid hormone biosynthesis” (p = 0:018), and
“various types of n-glycan biosynthesis” (p = 0:009)
(Figure 5(c)). In contrast, several functional pathways were
enriched in the microbiota of the obese group: “cysteine
and methionine metabolism” (p = 0:004); “peptidoglycan
biosynthesis” (p = 0:017); “phenylalanine, tyrosine, and
tryptophan biosynthesis” (p = 0:046); “photosynthesis”
(p = 0:008); and “seleno-compound metabolism” (p = 0:004)
(Figure 5(c)).
4. Discussion
The present study showed differences in gut microbial com-
position between young normal-weight and obese Korean
children aged 5-13 years. Obese children showed a significant
reduction in Bacteroidetes, an elevated F : B ratio, and signif-
icantly different beta diversity compared with the same
parameters among normal-weight children, as described by
previous studies [4, 25, 26]. The Bacteroidetes population
was also detected by LEfSe with a high LDA score, suggesting
that it is the key phylotype responsible for the differences
between the normal-weight and obese groups. The relative
abundance of Firmicutes, however, revealed no significant
difference between the groups. The results of our study sug-
gest the importance of Bacteroidetes in pediatric obesity.
Recent evidence has indicated that Bacteroidetes is a poten-
tially modifiable therapeutic target because it is more largely
influenced by environmental factors rather than host genet-
ics [4, 27, 28]. In the future, prospective intervention studies
will be needed to explore the impact of the specific species or
strains belonging to the Bacteroidetes phylum on pediatric
obesity modulation. Family Lachnospiraceae was signifi-
cantly correlated with BMI z-score. This result is consistent
with a previous experimental result showing that the coloni-
zation of bacteria belonging to Lachnospiraceae induces the
development of diabetes in germ-free ob/ob mice [29]. From
these findings, it could be assumed that Lachnospiraceae is
involved in the development of metabolic dysfunction in
children. Akkermansia is a mucin-degrading bacterium,
and its abundance has been reported to be negatively corre-
lated with obesity in previous studies with adults [30]. In
one study, Akkermansia was reduced in obese children aged
4-5 years living in Sweden, which was analyzed by quantita-
tive PCR [31]. However, the current reports including our
study, using 16S rRNA next generation sequencing analysis,
revealed no significant difference in Akkermansia levels
between normal-weight and obese children [32, 33]. This dis-
parity can be explained with the differences in the methodol-
ogy, ethnicity, and extent of its colonization which starts
from early childhood and reaches a similar level to adults
[34].
To investigate the relationships between gut microbial
community composition, BMI, and selected variables from
the biochemical markers and diet intake, CCA analysis was
performed. The gut microbial community in the obesity
group revealed a strong correlation with BMI z-score, which
was in line with previous reports [35, 36]. Inflammatory
markers, including hs-CRP, neutrophil count, and ferritin,
were related to microbial composition in the obese group,
suggesting that obesity is closely linked to inflammation
[37]. Evidence for a relationship between inflammation and
the microbiota continues to be revealed. Bacterial products,
such as lipopolysaccharide and short-chain fatty acids
(SCFAs), can induce inflammation through immune cell
activation and fat accumulation in adipocytes [38, 39]. These
findings suggest the role of the gut microbiota in the develop-
ment of inflammation in the pathogenesis of pediatric obe-
sity. Among dietary intakes, niacin, Na, and fat seemed to
affect gut microbial composition in the obese group. Higher
fat and Na intake is associated with obesity and metabolic
syndrome [40, 41]. Moreover, a recent study indicated the
possible association of chronic niacin overload on pediatric
obesity [42]. In our study, dietary intake of vitamin B6
seemed to be important in the microbial community of
normal-weight children. Prior work has suggested that the
gut microbiota of lean adolescents seems to be more involved
Table 5: Continued.





Romboutsia sedimentorum 0.387 0.008
Roseburia_uc 0.386 0.008
Senegalimassilia anaerobia 0.355 0.016
∗Pearson’s correlation coefficient. ∗∗Taxa with p values > 0.05 were omitted.
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in vitamin B6 synthesis [25]. Further research is needed to
corroborate the present results. The correlation network of
the gut microbiota in this study showed that the normal-
weight group had less clustering of genera than the obese
group. This finding is consistent with prior studies by Riva
et al. [32], showing that the gut microbiota in the obese group
has a different correlation network structure than the gut
microbiota in the normal-weight group.
The mechanisms by which the microbiota affects energy
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Figure 2: Linear discriminant analysis (LDA) coupled with effect size measurement (LEfSe) analysis identified the most differentially
abundant taxa that distinguished the normal-weight group from the obese group. Comparison of relative abundance at the bacterial
phylum (a), class (b), order (c), family (d), and genus € levels between the normal-weight and obese groups. LDA scores from LEfSe
analysis, including the phylum, class, order, family, genus, and species levels (f). The enriched bacterial taxa of the normal-weight group
are marked with green bars, and the taxa enriched in the obese group are indicated with red bars (f). Only taxa meeting an LDA
significance threshold > 2 are shown (f).
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the PICRUSt analysis showed that gut microbial function in
obese children involves energy metabolism, such as photo-
synthesis and nitrogen metabolism, which can stimulate lipo-
genesis or gluconeogenesis [43]. Recent research has revealed
that Bacteroides ovatus can release monosaccharides from
cellulose and hemic cellulose for further metabolism by a
wide variety of gut commensals via glycolytic pathways
[44]. Our results showed that carbohydrate metabolism was
more predicted in normal-weight children than in obese chil-
dren, which can be speculated to be related to the positive
association of Bacteriodes ovatus in normal-weight children.
Our functional analysis also showed a significantly greater
presentation of genes involved in amino acid metabolism,
such as cysteine and methionine metabolism and tyrosine
and phenylalanine biosynthesis, in obese children than in
normal-weight children. The fermentation pathways of cys-
teine and methionine are included in sulfur metabolism,
which leads to the production of hydrogen sulfide, which
has been known to have detrimental effects on colonic epi-
thelial energy metabolism [45, 46]. Tyrosine and phenylala-
nine biosynthesis are known to be associated with obesity,
diabetes, and metabolic syndrome by reducing the activation
of alkaline phosphatase [47, 48]. This result in our study may
have important long-term implications for bowel health in
the context of the consumption of excessive protein diets.
In addition, higher abundances of microbial communities
related to lipid metabolism were observed in normal-weight
children than in obese children [49]. These changes in pre-
dicted metabolic pathways caused by intestinal microbiota
can induce an imbalance between energy production and
absorption. The specific mechanism associated with this
functional analysis will need to be studied further.
In our study, hs-CRP, NLR, and MPV were higher in the
obese group than in the normal-weight group. hs-CRP and
NLR are well-known inflammatory markers that are associ-
ated with obesity because adipose tissue can be the major
source of proinflammatory cytokines [50]. Increased MPV,
a biomarker of platelet activity, is known to be associated
with acute myocardial infarction, stroke, and thrombosis in
individuals with morbid obesity [50]. The percentage of chil-
dren born by cesarean section was significantly higher in the
obese group than in the normal-weight group. This finding is
the same as those of previous studies, which are explained by
the disruption of mother-to-child transmission of gut micro-
biota associated with cesarean section [52, 53]. In regard to
lifestyle, the use of electronic devices is becoming a major
problem in the context of pediatric obesity rather than a lack
of physical activity [54]. The present study also indicated that












Figure 3: Correlation plot showing Pearson’s correlation coefficient between blood biochemical markers related to insulin resistance and
inflammation, major taxa, and dietary intake (a). Only statistically significant values are shown (p ≤ 0:05) (a). Positive correlations are
displayed in blue, and negative correlations are displayed in red (a). Color intensity and the size of the circle are proportional to the
correlation coefficients (a). Canonical correspondence analysis of gut microbial community composition at the phylum level with respect
to BMI z-score, blood biochemical markers including 25-OH vitamin D, neutrophil count, CRP, ferritin, and HOMA-IR (b), or dietary
intake including calories, fat, Na, niacin, Zn, P, and vitamin B6 (c). The blue lines indicate the direction and magnitude of variables
associated with bacterial community composition (b, c). Red dots represent different bacterial phyla, and black dots represent each patient
(O—obese group; N—normal-weight group) (b, c). Axes 1 and 2 can explain 80.4% of the data variance in the correlation between the
microbiota and blood biomarkers associated with inflammation and metabolic syndrome (b). Axes 1 and 2 can explain 83.5% of the data
variance in the correlation between microbiota and dietary intake (c). Abbreviations: VitD—25-OH vitamin D; Ntcount—neutrophil
count; CRP—high-sensitivity C-reactive protein; BMI_Z—body mass index z-score; HOMA_IR—the homeostasis model assessment-
estimated insulin resistance; Zn—zinc; TGs—triglycerides; VitB6—vitamin B6.











Figure 4: Correlation network analysis of the gut microbiome of the normal-weight (a) and obese (b) groups. Each node shows one genus,
and nodes are colored by phylum affiliation. The color of the edges shows positive (green) and negative (red) pairwise correlations between
genera. The color intensity of the edges indicates the relative strength of the correlation. Genera with sample coverage < 0:5 and correlations
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Figure 5: Distribution of tier 1 KEGG functional categories from the normal-weight (green) and obese (red) groups (a). Significant
differences in the relative abundances of second (b) and third (c) tier KEGG functional categories between the normal-weight (orange)
and obese (green) groups. Significance was determined using the Kruskal-Wallis test with FDR correction. Only functional categories with
corrected p < 0:05 are shown.
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not only the lack of exercise but also the use of electronic
devices for more than two hours a day was significantly
higher in the obesity group. A recent study reported that elec-
tronic device usage close to bedtime can disrupt sleep pat-
terns, which could lead to obesity [55]. Obesity is not only
microbiota-driven; thus, a careful evaluation of all factors,
including delivery mode, diet, and lifestyle, should be taken
into account [56].
One of the strengths of this study is that it included only
young Korean children, which makes the study population
less influenced by ethnicity and environmental factors such
as smoking, drugs, and alcohol use. Instead of simply com-
paring the microbiota between groups, we analyzed the rela-
tionship of multivariate factors in the microbiota,
biochemical markers, and diet intake through a correlogram
and CCA. Additionally, we showed the results of a network
analysis and functional analysis of the gut microbiota in
obese and normal-weight young children. The limitations
of this study had to do with the small number of participants
and the cross-sectional design, which prevents the determi-
nation of causality. Therefore, a prospective large-scale study
is required to clarify the relationship between the microbiota
and childhood obesity.
In conclusion, the microbial communities of obese chil-
dren exhibited significant differences in beta diversity and a
significantly elevated F : B ratio compared to those in
normal-weight children. The phylum Bacteroidetes was sig-
nificantly reduced in the obese group and was negatively cor-
related with BMI z-score. The LEfSe biomarker discovery
analysis also suggested that the Bacteroidetes population
was the key phylotype differentiating the two groups. These
findings suggest the importance of Bacteroidetes in pediatric
obesity. The gut microbial community in the obese group
was linked to BMI z-score; blood biomarkers associated with
inflammation and metabolic syndrome; and intakes of nia-
cin, Na, and fat. In the microbial network analysis, the gut
microbiota in the obese group showed more clustering of
genera than the gut microbiota in the normal-weight group.
PICRUSt analysis revealed that the functions related to car-
bohydrate and lipid metabolism were more enriched in the
microbiota of the normal-weight group than in that of the
obese group. Our data may contribute to the understanding
of the gut microbial structure of young Korean children in
relation to obesity. Further studies are required to target Bac-
teroidetes as a new therapeutic intervention for pediatric
obesity.
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